Dizal (Jiangsu) Pharmaceutical Co. Ltd.SSE: 688192

Announcement on Voluntary Disclosure of Multiple Latest Research Advances in Lung Cancer at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

· Issued by Dizal (Jiangsu) Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

On 6ix: 6ix.com/news/announcement-on-voluntary-disclosure-of-multiple-latest-research-advances-in-lung-cancer-at-the-2026-american-society-of-clinical-oncology-asco-annual-meeting

Announcement on Voluntary Disclosure of Multiple Latest Research Advances in Lung Cancer at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Dizal (Jiangsu) Pharmaceutical Co. Ltd. on 6ix

Earlier from Dizal (Jiangsu) Pharmaceutical

Later from Dizal (Jiangsu) Pharmaceutical

All Dizal (Jiangsu) Pharmaceutical news releases